Annual Report for Fiscal Year Ending December 31, 2023 (Form 10-K)
A Marketer’s Guide to Driving Growth With B2B In-Person Events
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing[...]
05/23/2022 | Press release | Distributed by Public on 05/22/2022 17:49
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact